# C_2013231EN.01000801.xml

| 9.8.2013 | EN | Official Journal of the European Union | C 231/8 |
| --- | --- | --- | --- |

9.8.2013

EN

Official Journal of the European Union

C 231/8

---

Prior notification of a concentration

(Case COMP/M.7002 — M&G/Alliance Medical)

Candidate case for simplified procedure

(Text with EEA relevance)

2013/C 231/09

| 1. | On 2 August 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which M&G Investment Management Limited (‘M&G’, United Kingdom), controlled by Prudential plc (United Kingdom), acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the Alliance Medical group of companies (‘Alliance Medical’, United Kingdom), by way of a debt-to-equity swap. |
| --- | --- |

1.

On 2 August 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which M&G Investment Management Limited (‘M&G’, United Kingdom), controlled by Prudential plc (United Kingdom), acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the Alliance Medical group of companies (‘Alliance Medical’, United Kingdom), by way of a debt-to-equity swap.

1

| 2. | The business activities of the undertakings concerned are:






  — | for M&G: a wholly-owned subsidiary of Prudential plc, an international insurance group, and the investment management division of Prudential plc in Europe, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for M&G: a wholly-owned subsidiary of Prudential plc, an international insurance group, and the investment management division of Prudential plc in Europe,

| — | for Alliance Medical: primarily the provision of outsourced diagnostic imaging services for hospitals and doctors' surgeries, and the manufacture and distribution of radiopharmaceuticals and tracers used for diagnostic imaging. |
| --- | --- |

—

for Alliance Medical: primarily the provision of outsourced diagnostic imaging services for hospitals and doctors' surgeries, and the manufacture and distribution of radiopharmaceuticals and tracers used for diagnostic imaging.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.7002 — M&G/Alliance Medical, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.7002 — M&G/Alliance Medical, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

1

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

2

---